Fresenius Medical Care is the largest operator in the United States of hemodialysis clinics. One of their main dialysis products is GranuFlo. Recent information has been released suggesting that GranuFlo may cause heart attacks or other cardiac issues when not used in the proper dose.
Until now, many doctors who administered GranuFlo were unaware of the severe dangers caused by GranuFlo including heart attacks and cardiac arrest. GranuFlo is a product that uses more bicarbonate than rival products and bicarbonate has been linked with causing heart trauma and even death. Doctors who did not operate at Fresenius’ own dialysis clinics were not initially provided with the information that GranuFlo and Naturalyte have higher amounts of bicarbonate.
Most patients who undergo dialysis don’t question that the products they are using are safe. If you or a loved one has suffered from a heart trauma like a GranuFlo heart attack, you may be entitled to financial compensation. Please contact a GranuFlo lawyer to discuss your potential case and your options going forward.
The majority of dialysis patients are not even aware of the names of the products they use, such as GranuFlo and Naturalyte. In addition, people may be unaware that the facilities at which they are undergoing dialysis are owned by Fresenius as many of the facilities do not have branded names.
Many people are disturbed by the fact that the makers of GranuFlo did not believe it was important to warn all patients and dialysis centers that were administering the dangerous product. They instead only made the warning available to their own dialysis centers. Many people have died from heart ailments traced to the use of Fresenius’ products during dialysis. If you or a loved one have suffered from a GranuFlo heart attack, we suggest you contact a GranuFlo heart attack lawyer to discuss your options for a GranuFlo lawsuit.
One director of a major dialysis center reported that the bicarbonate levels among patients at their center were too high in more than 30% of their patients. Increases in cardiac events of this magnitude are reason for alarm in many of the dialysis centers across the country.
Fresenius is currently under investigation by the FDA to see whether the company violated federal regulations by not alerting all customers of GranuFlo & NaturaLyte of the health risks. The FDA issued a Class 1 recall of GranuFlo & NaturaLyte from all clinics on June 27, 2012.
If you or a loved one has experienced cardiac arrest, heart attack, stroke following dialysis with GranuFlo or Naturalyte, please contact the Willis Law Firm for a free consultation for a potential dialysis lawsuit. Call 1-800-883-9858 to speak to lawyer or CLICK HERE